April news includes tools to manage brain injury and predict recovery, new drug hits and misses, and an updated epilepsy classification system.
Epilepsy and Seizure
Experimental data suggesting benefits of cannabinoid comes from purified, standardized preparations that may not translate to real world practice.
Studies include stroke risk with epilepsy, genetic predisposition for ischemic stroke, and dysphagia screening in stroke patients.
March news includes possible brain tumor therapies, a study exploring mechanisms underlying demyelination-induced seizures, and VNS post stroke.
Common presentations between epilepsy and syncope complicate the differential diagnosis, making syncope the most frequent misdiagnosis in epilepsy.
Researchers evaluated several databases to determine whether or not depression has a causative role on epilepsy, or vice versa.
Ten general and disease-specific apps for neurologists include assessment scales, anatomical diagrams, and interactive clinical decision support.
February news includes stroke risk with Alzheimer disease & migraine, neonatal hemorrhagic stroke, and head trauma in sports.
Stroke is the most common cause of epilepsy in older adults, but there is limited information about rates and risk factors in this population.
Previous studies of methylphenidate in epilepsy patients have suffered from small numbers and methodological issues, such as lack of blinding.